These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, Park HC, Suh CO, Park TK, Kim BS. Cancer; 2002 Aug 01; 95(3):531-9. PubMed ID: 12209745 [Abstract] [Full Text] [Related]
8. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases. Zati Zehni A, Jeschke U, Hester A, Kolben T, Ditsch N, Jacob SN, Mumm JN, Heidegger HH, Mahner S, Vilsmaier T. Int J Mol Sci; 2020 Jun 22; 21(12):. PubMed ID: 32580276 [Abstract] [Full Text] [Related]
9. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. Halle MK, Ojesina AI, Engerud H, Woie K, Tangen IL, Holst F, Høivik E, Kusonmano K, Haldorsen IS, Vintermyr OK, Trovik J, Bertelsen BI, Salvesen HB, Krakstad C. Am J Obstet Gynecol; 2017 Oct 22; 217(4):432.e1-432.e17. PubMed ID: 28599900 [Abstract] [Full Text] [Related]
10. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T. Gynecol Oncol; 2012 Oct 22; 127(1):114-20. PubMed ID: 22728518 [Abstract] [Full Text] [Related]
11. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer. Czogalla B, Kuhn C, Heublein S, Schmöckel E, Mayr D, Kolben T, Trillsch F, Burges A, Mahner S, Jeschke U, Hester A. J Cancer Res Clin Oncol; 2019 Oct 22; 145(10):2519-2527. PubMed ID: 31485769 [Abstract] [Full Text] [Related]
12. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY. Gynecol Oncol; 1999 May 22; 73(2):184-90. PubMed ID: 10329032 [Abstract] [Full Text] [Related]
13. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement. Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F. Hum Pathol; 2013 Feb 22; 44(2):181-8. PubMed ID: 22974479 [Abstract] [Full Text] [Related]
14. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. Yokoi E, Mabuchi S, Takahashi R, Matsumoto Y, Kuroda H, Kozasa K, Kimura T. J Gynecol Oncol; 2017 Mar 22; 28(2):e19. PubMed ID: 28028992 [Abstract] [Full Text] [Related]
15. The role of EP-2 receptor expression in cervical intraepithelial neoplasia. Schmoeckel E, Fraungruber P, Kuhn C, Jeschke U, Mahner S, Kolben TM, Kolben T, Vilsmaier T, Hester A, Heidegger HH. Histochem Cell Biol; 2020 Dec 22; 154(6):655-662. PubMed ID: 32851536 [Abstract] [Full Text] [Related]